Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP

Deconjugation of soy isoflavone glucuronides needed for estrogenic activity

(2015) M.A. Islam et al.   TOXICOLOGY IN VITRO

Interplay between metabolism and transport of resveratrol

(2013) Alexandra Maier-Salamon et al.   Annals of the New York Academy of Sciences

Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP

(2012) Hiroyuki Kusuhara et al.   BRITISH JOURNAL OF PHARMACOLOGY

Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells

(2011) Walter Brand et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Bioavailability of the Glucuronide and Sulfate Conjugates of Genistein and Daidzein in Breast Cancer Resistance Protein 1 Knockout Mice

(2011) A. I. Alvarez et al.   DRUG METABOLISM AND DISPOSITION

Interpretation of the Effects of Protein Kinase C Inhibitors on Human UDP-glucuronosyltransferase 1A (UGT1A) Proteins in cellulo

(2011) Yuko Abe et al.   Drug Metabolism and Pharmacokinetics

Characterization of trans-Resveratrol-Loaded Lipid-Core Nanocapsules and Tissue Distribution Studies in Rats

(2011) Rudimar L. Frozza et al.   Journal of Biomedical Nanotechnology

Enhancing the bioavailability of resveratrol by combining it with piperine

(2011) Jeremy J. Johnson et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Breast Cancer Resistance Protein (BCRP) and Sulfotransferases Contribute Significantly to the Disposition of Genistein in Mouse Intestine

(2010) Wei Zhu et al.   AAPS Journal

Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients

(2010) K. R. Patel et al.   CANCER RESEARCH

Involvement of Breast Cancer Resistance Protein (BCRP1/ABCG2) in the Bioavailability and Tissue Distribution oftrans-Resveratrol in Knockout Mice

(2010) Irene Alfaras et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites

(2010) Juma Hoshino et al.   JOURNAL OF MEDICINAL CHEMISTRY

Membrane transporters in drug development

(2010)   NATURE REVIEWS DRUG DISCOVERY

Functional Characterization of Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) in the Basolateral Efflux of Glucuronide Conjugates in the Mouse Small Intestine

(2009) Y. Kitamura et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

(2008) N. Dhillon et al.   CLINICAL CANCER RESEARCH

Curcuminoids Inhibit Multiple Human Cytochromes P450, UDP-Glucuronosyltransferase, and Sulfotransferase Enzymes, whereas Piperine Is a Relatively Selective CYP3A4 Inhibitor

(2008) L. P. Volak et al.   DRUG METABOLISM AND DISPOSITION

The Major Chemical-detoxifying System of UDP-glucuronosyltransferases Requires Regulated Phosphorylation Supported by Protein Kinase C

(2008) Nikhil K. Basu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol

(2008) K. van de Wetering et al.   MOLECULAR PHARMACOLOGY

Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice

(2008) Suneet Shukla et al.   PHARMACEUTICAL RESEARCH

Metabolism and Disposition of Resveratrol in the Isolated Perfused Rat Liver: Role of Mrp2 in the Biliary Excretion of Glucuronides

(2007) Alexandra Maier‐Salamon et al.   JOURNAL OF PHARMACEUTICAL SCIENCES